Observational study / 2020
Ashwagandha use was linked to cholestatic or mixed liver injury with jaundice that normalized within 1 to 5 months.
A case series analyzed 5 patients (3 from Iceland, 2 from the US DILIN) with liver injury attributed to ashwagandha-containing supplements. After a latency of 2-12 weeks, all patients developed jaundice and symptoms like nausea, lethargy, pruritus, and abdominal discomfort. Liver injury was cholestatic or mixed (R ratios 1.4-3.3), with prolonged pruritus and hyperbilirubinemia (5-20 weeks), but no patient developed hepatic failure. Liver tests normalized within 1-5 months in four patients (one was lost to follow-up), and one biopsy showed acute cholestatic hepatitis.
Shows an association, not proof of cause and effect.
- Study type
- Case series
- Who was studied
- 5 patients with suspected liver injury attributed to ashwagandha (3 males, mean age 43 years, range 21-62)
- What was measured
- Clinical phenotype, liver injury pattern, and resolution of ashwagandha-induced liver injury
THE PAPER
Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.
Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V. Liver Int, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.